EU is working on reservation: Spahn calls for delivery of a Corona-drug Remdesivir
Federal Minister of health, Jens Spahn calls from the manufacturer of the corona drug Remdesivir despite a large-scale purchase, the United States continued ability to supply.
He was waiting by the pharmaceutical company Gilead Sciences, “that Germany and Europe are supplied when it comes to such a drug,” said the CDU politician on Thursday in the ZDF morning magazine’.
The need for the coming weeks Spahn looks to be already secured. In the Central pharmacy of the Federal government there are appropriate reserves.
Also, the European Union aims to secure sufficient quantities of the Corona By means of Remdesivir. It will be negotiated with the manufacturer, Gilead Sciences, announced a spokesman for the EU Commission on Thursday.
He reiterated at the same time that the medium is expected to be the end of this week for the European market.
USA secure Remdesivir supplies
Remdesivir is considered to be one of the few effective drugs for severe cases of the Coronavirus-induced lung disease Covid-19.
It can be shorten according to studies, the hospital stay. The US government had made an agreement with Gilead announced that it has practically buys the whole production amount of By means of for the next few months.
However, for example, Germany has already created inventories of the product.
The EU Commission spokesman said it is negotiating with the manufacturer, a reservation of a sufficient number of treatment doses of the Agent.
The negotiations are at an early stage. On the quantity and the cost he wanted to say anything.
The European medicines Agency EMA had recommended last week for an authorisation of the active substance for the treatment of Covid-19 in certain cases.
The last steps in the approval is an approval of the EU States, as well as the formal decision of the EU Commission.
The conclusion of the proceedings is expected for this Friday. The EMA recommends that the treatment for patients aged twelve years, a pneumonia, and supplemental oxygen must be supplied.
Remdesivir was originally developed for the treatment of Ebola, showed that this infectious disease but to little effect.
Deutsche Presse-Agentur (dpa)
*The post “EU is working on reservation: Spahn calls for delivery of a Corona-drug Remdesivir” is published by FitForFun. Contact with the executives here.